Metaplastic Breast Carcinoma: Case Series and Review of the Literature

Esbah, Onur; Turkoz, Fatma P.; Turker, Ibrahim; Durnali, Ayse; Ekinci, Ahmet S.; Bal, Oznur; Sonmez, Ozlem Uysal; Budakoglu, Burcin; Arslan, Ulku Y.; Oksuzoglu, Berna

추천

검색

자료유형: 학술저널

저자정보: Esbah, Onur (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Turkoz, Fatma P. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Turker, Ibrahim (Department of Medical Oncology, Trabzon Research and Training Hospital) Durnali, Ayse (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Ekinci, Ahmet S. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Bal, Oznur (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Sonmez, Ozlem Uysal (Department of Medical Oncology, Sakarya Research and Training Hospital) Budakoglu, Burcin (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Arslan, Ulku Y. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital) Oksuzoglu, Berna (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제9호

발행연도: 2012.1

수록면: 4,645 - 4,649 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Metaplastic breast carcinoma (MpBC) is a rare disease entity, accounting for less than 1% of all breast carcinomas. Furthermore, it is a heterogenous disease with different subgroups, including malignant epithelial (carcinoma) and stromal (sarcoma) features. Here we evaluated, retrospectively, 14 female MpBC patients admitted to Ankara Oncology Training and Research Hospital between 2005 and 2011. Median age was 45.5 (range:16.0-76.0) and tumor size 57.5 mm (range: 20.0-80.0 mm). Histopathological subtypes were as follows: 5 carcinosarcoma, 5 squamous and 4 adenosquamous carcinoma. All but one with upfront lung metastasis, had their primary breast tumor operated. Axillary lymph nodes were involved in 64.3%. The most common sites of metastasis were lungs and brain. Chemotherapy including antracycline, taxane and even platinium was planned for adjuvant, neoadjuvant and palliative purposes in 9, 3 and 1 patient, respectively. Median cycles of chemotherapy was 6 (range:4-8). Median follow-up of the patients was 52 months (95%CI 10.4-93.6 month). Median 3 year progression free survival (PFS) and overall survival (OS) in this patients cohort were 33% and 56%, respectively. In conclusion, MpBC is a rare and orphan disease without standardized treatment approaches and the prognosis is poor so that larger studies to investigate different treatment schedules are urgently needed.

#Breast metaplastic carcinoma #rare disease #orphan status #poor prognosis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요